Hypothesis: cytokines may be activated to cause depressive illness and chronic fatigue syndrome

E Ur1, P D White, A Grossman

  • 1Department of Endocrinology, St. Bartholomew's Hospital, London, England.

Insights

Cytokine activation in the brain may cause hyperactivity of the corticotropin-releasing hormone (CRH) axis, potentially explaining major depression and chronic fatigue symptoms. This novel hypothesis suggests a new avenue for understanding these complex conditions.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Immunology

Background:

  • Dysregulation of the hypothalamo-pituitary-adrenal (HPA) axis is a known characteristic of endogenous depression.
  • The precise mechanisms driving HPA axis abnormalities in depression remain unclear, though excessive corticotropin-releasing hormone (CRH) activity is implicated.

Purpose of the Study:

  • To propose a novel hypothesis linking cytokine activation in the brain to CRH hyperactivity and major depressive disorder.
  • To explore the potential role of interleukins (IL-1 and IL-6) in the pathogenesis of depression and related disorders.

Main Methods:

  • This study presents a theoretical framework and hypothesis, rather than empirical data collection.
  • It suggests experimental strategies to validate or refute the proposed link between cytokines and HPA axis dysfunction in depression.

Main Results:

  • The hypothesis posits that cytokine activation (IL-1, IL-6), potentially triggered by factors like viral infections, leads to CRH hyperactivity.
  • This CRH hyperactivity, influenced by cytokines, may underlie key features of major depression, especially those involving chronic fatigue.

Conclusions:

  • Cytokine-induced CRH hyperactivity offers a potential etiological explanation for aspects of major depression and related conditions.
  • The proposed theory provides a heuristic framework for future research into the neurobiological underpinnings of depression.

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...